Syringe without needle has limitations still has potential market

History is always in the development of science is always in progress. Though traditional syringe has solved many problems to mankind, have brought many convenient, but with the progress of science and technology, the traditional needle syringe itself exists some problems, such as easy to cause infectious disease spread, needles infection, encouraging people to find new injection method, there is no these problems. So, was born in a sterile syringe without needle. It is understood that the syringe without needle development began in the early 1980 s the United States, approved specifically for insulin injections. According to introduction, this product works, using ultrasonic and high pressure liquid atomization insulin after ultrafine particle aerosol formation, under high pressure, the insulin aerosol diffusion through tiny pores in the skin into the subcutaneous, thus completing the process of injection. Until 1990 years later, more sophisticated spring as power began to appear in a sterile syringe without needle, and the pore size, pressure control, flow speed, the energy curve, and solution of distribution, the absorption of drug, etc., carried out a more reasonable design and research, and non invasive syringe are truly mature. The personage inside course of study for our syringe without needle made an analysis of marketing: the diabetes patients in China more than 80 million people, and the trend of increasing every year, of which about half of the patients to long-term injection of insulin. Considering the factors such as marketing promotion schedule and purchasing power, only the part of the group of 2.5% of the patients with positioning goal for the future use of the crowd, is the scale of up to 1 million people. Without needle injection technology can also be derived different specifications, different clinical USES of syringe without needle, as a result, the subsequent product should have a broader space, such as vaccination, narcotic injection products, pre filled syringe without needle, syringe for infectious disease hospital, and to meet the requirements of ophthalmology, dental, etc. Using high fine for injection syringe without needle and syringe without needle for cosmetic surgery. Etc. So calculate down, syringe without needle domestic market potential is expected to more than $ten billion. However, syringe without needle subsequent product research and development production is not easy. Research and development and production of syringe without needle needs of clinical medicine, physiology, fluid mechanics, laser physics, mechanical, and other professional and technical personnel to participate in. At present, there are dozens of international companies and research institutions engaged in the product research and development, but the real mature licensed products are rare. Many research institutions and enterprises in our country also in research and development in a sterile syringe without needle has spent a lot of effort, but only part of the syringe without needle parts come out. Syringe without needle scope is very wide, can be widely used in all kinds of vaccine, prevention and treatment of infectious diseases, all kinds of medication, and diabetes patients that need to be self injection group. This product has a very broad market in our country, to solve many of the current medical demand, is very meaningful. Syringe without needle, however, because itself has limitations, can only be used for small dose of protein and polypeptide drugs, not injection clinical demand a great deal of antipyretic analgesics, antibiotics or antitumor drugs, greatly limits its application in clinical practice, which is another main reason lies in its price. The personage inside course of study thinks, considering the research and development technology bottlenecks, clinical study and review cycle, in order to keep leading advantage, the first task is to expand capacity, strengthening marketing and accelerate the subsequent product launch. Hypospray, experts say, is not only suitable for ordinary injection syringe injection liquid fuel, it still has a for ordinary cylinder injector "dust" advantage, can be directly to the intradermal powder drug particles does not dissolve in water. Another advantage is that it is very suitable for large scale prevention of epidemic disease broke out for mass injection of preventive medicine. So efficient injection velocity is unmatched by ordinary cylinder injector.
With international pharmaceutical market more and more new products are available in a sterile syringe without needle, an American economist, prediction: in the next few years, more and more convenient and easy to use syringe without needle new products will gradually from the existing market share of disposable syringe, and become the 21st century international syringe the mainstream products on the market, its development space is enormous. By 2010, the global market in a sterile syringe without needle total sales will reach $3 billion. Our country is the world's largest producer and exporter of disposable needles, so the western developed countries the rapid development of the syringe without needle syringes export market of our country have an impact. At the same time, we must believe that in the future, syringe without needle market development will be better and better.
http://medical-supplies.cc/